Robert N. Weingarten

Insider Reports History

Identity
Location
Woodland Hills, CA
SEC record
Reporting signature
/s/ Robert Weingarten
SEC evidence
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Robert N. Weingarten:

Form 4 holding Vice President and CFO

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Security class
Stock Options
Shares / value
200,000
Estimated value
Report date
06 Nov 2022
Price
Ownership
Direct
Underlying class
Common
Underlying amount
Form 4 holding Director

Guardion Health Sciences, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
334
Estimated value
Report date
30 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Robert N. Weingarten

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .